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parameters, LV mass, scan time and report time were evaluated
in each patient for both sequences. Differences between
functional parameters and LV mass were made with a paired
Student’s T test; correlation between parameters was assessed
with Pearson’s correlation coefficient. A Bland-Altman analysis
was used to investigate the limits of agreement between the
measurements. Differences between time-efficiency related
parameters were made with a paired Student’s T test.
Results: Functional parameters and mass were significantly
different in the two sequences (p < 0.05) but a strong correlation
was found for LVejection fraction (r = 0.96) and good correlation for
other functional parameters (r between 0.83 and 0.93). Scan time
was significantly lower for 3D sequence, report timewas significantly
higher for 3D sequence.
Conclusion: 3D k-t BLAST sequence can be used to assess EF
in patients who have poor compliance in performing multiple
apnoeas and in patients who are not able to remain in the
scanner for a long time. Conversely report time is significantly
higher for 3D sequence.
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Introduction: Iron induced cardiomiopathy is the main cause
of mortality in thalassemic population. Thus, the improvement of
chelation regimens, to reduce cardiac disease, has the highest
priority. Efficient evaluation of cardiac iron status and careful
epidemiologic assessment of thalassemic patients play an
important role in this matter. T2* cardiac magnetic resonance
imaging (CMR) is a unique technique to quantify myocardial iron
overload and useful to tailor the chelation therapy. In particular,
effective and reproducible assessment of myocardial iron loading
using the multislice multiecho T2* approach for segmental and
global myocardial iron distribution has been demonstrated within
a single CMR site. Thalassemia major (TM) patients require
lifelong myocardial iron load monitoring to assess the effective-
ness of chelation therapies. Hence, it is highly desirable that CMR
be performed near the patients’ locations, and that the patients
be able to safely move between different CMR centers.
Purpose: Aim of this work is to build a reliable network of
haematological and paediatric centers specializing in thalassemia
care and MRI sites able to perform feasible and reproducible
heart iron overload assessments for a consistent number of
thalassemia patients in a standardized and robust manner.
Materials and methods: In order to assess the transferability
of the multislice multiecho T2* technique, heart multislice
multiecho T2* sequence was installed on 1.5 T MRI scanners (GE
Healthcare) at six different sites. Five healthy subjects at each site
(n = 30) were scanned to verify the homogeneity of normal
ranges (T2* lover limit of normal 20 ms). Then, five TM patients
were scanned at the reference site and were rescanned locally
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(n = 25) within one month. T2* images were analysed using a
previously validated software (HIPPO MIOT®).
After the assessment of CMR technique reproducibility, patients
enrolling started in September 2006. A centralized data manage-
ment system was made to share patient data between CMR and
thalassemia sites. It allowed optimizing the TM patients care and
favouring the creation of a clinical-instrumental database with
data exchange facilities to develop diagnostic, prognostic and
therapeutical evidence-based treatments for thalassemia patients.
The study was approved by the local ethics committees and
followed the principles outlined in the Declaration of Helsinki.
Results: Global and segmental T2* values of healthy subjects
showed inter-sites homogeneity. On TM patients, for global heart
T2* values the correlation coefficient was 0.97, Coefficients of
Variation (CoVs) ranged from 0.04 to 0.12 and Intraclass
Coefficients (ICCs) ranged from 0.94 to 0.99. The mean CoV
and ICC for segmental T2* distribution were 0.198 and 88,
respectively. Figure 1A shows linear regression of global heart
T2* values obtained from 25 (5 × 5) patients who were scanned
at the reference site and locally at each of the other five sites on
the same conditions.
Since the project’s beginning, 695 thalassemia patients have been
involved in the network. 630 patients (90%) successfully under-
went CMR examination. Twenty patients (3%) refused CMR,
mainly due to claustrophobia. The remaining patients (7%) have
been scheduled for future examination. The mean distance from
the patient home locations to the CMR site where the patients
underwent the exams, which is considered an indicator of patient
comfort, significantly decreased during the network’s evolution.
In Figure 1B, the average distances from the thalassemia centers
which sent the patients for CMR examination are plotted versus
time.
Conclusion: The multislice multiecho T2* technique is trans-
ferable among scanners with good reproducibility. The network
seems to be a robust and scalable system in which T2* CMR-
based cardiac iron overload assessment is available, accessible
and reachable for a significant and increasing number of
thalassemia patients, reducing the mean distance from the
patients’ locations to the CMR sites.
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Introduction: Despite the advantage of increased signal-noise-
ratio, skepticism exists regarding the use of 3 T as the primary
scanner for routine clinical CMR examination due to potential
for gating difficulties related to the increased magnetohydrody-
namic effect, off-resonance artifacts, and patient heating. We
quantified the diagnostic potential and artifacts based on our
experience of the first 4 months of routine clinical 3 T CMR
exams in a tertiary clinical center.
Purpose: To test the hypothesis that 3 T MRI is practical in
serving a busy clinical CMR service as the primary routine
cardiac scanner.
Methods: Two-hundred and eighty patients were referred for
CMR for a broad range of clinical indications over a 4-month
period and underwent a 3 T cardiac MRI scan (MAGNETOM Tim
Trio, Siemens, Germany). Three experienced readers quantified
total scan time, troubleshooting time for 3 T-related off-
resonance artifacts, image quality, and artifacts in all pulse
sequences performed. Image quality was graded per accepted
criteria (1-Non diagnostic, 2-diagnosis suspected but not
established with severe blurring, 3-definite diagnosis despite
moderate blurring, 4-definite diagnosis with only mild blurring,
5-definite diagnosis without visible blurring). Artifacts severity
was graded in a 5-point scale (1-No artifacts, 2-minimal artifacts,
good diagnostic quality images, 3-moderate artifact and diagnosis
established, 4-considerable artifacts, diagnosis suspected but not
established, 5 – severe artifacts, non diagnostic images). Excellent
image quality was classified as a score ≥ 4 and minimal or no
artifact was classified as an artifact score of ≤ 2. Forty-six 1.5 T
CMR studies performed at the same study period with a matched
spread of indications were randomly selected as a control group
for comparison.
Results: On average, 2.8 minutes (5% of total scan time) were
spent to eliminate off-resonance banding artifacts in 3 T. This
time is made up by more aggressive accelerated parallel imaging
technique. As a result, average total scan time using 3 Twas not
different from 1.5 T (54 ± 14 vs. 54 ± 12 minutes, P = 0.47). No
patients failed to complete the study due to SAR limit. There
were no complications during any of the 1.5 T or 3 T CMR
studies. A significantly higher proportion of perfusion images
were graded as being of excellent quality on 3 Twhen compared
to 1.5 T (82.4% vs. 41.4%, p < 0.0001) (Figure 1). A significantly
higher number of perfusion images also had minimal or no
artifact on 3 T when compared to 1.5 T (93.7% vs. 72.4%,
p = 0.0016). When LGE images were analyzed, a significantly
higher proportion of images on 3 T were graded as being
excellent (82.6% vs. 46.2%, p < 0.0001) and the proportion of
LGE images having minimal or no artifact was also significantly
higher on 3 T (83.0% vs. 56.4%, p = 0.0042). The number of Cine
SSFP, pulmonary vein MRA, and phase contrast images that were
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Excellent image quality achieved (grade 4 or 5).
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